Integrated Biosciences Raises $17 Million

Silicon Valley biotech Integrated Biosciences has raised $17.2 million in seed financing to develop therapeutics for age-related diseases. The funding round included Sutter Hill Ventures, Lifespan Vision Ventures, Root Ventures, Civilization Ventures, Illumina Ventures Labs and additional funding sources. Founded in 2022,…


Helaina raises $45m for new healthy aging protein product

Helaina has announced a successful $45 million Series B funding round, bringing its total equity funding to $83 million, which will be used to further the development of effera Human Lactoferrin, a protein product designed to support women’s health, active nutrition…


Insilico Medicine reports positive Phase IIa results for ISM001-055 for the treatment of idiopathic pulmonary fibrosis (IPF) designed using generative AI

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced positive preliminary results from its Phase IIa clinical trial evaluating ISM001-055, a first-in-class small molecule targeting TNIK (Traf2- and Nck-interacting kinase). ISM001-055 was designed using a unique AI platform to…